Terrence L. Geiger

1 Patent

• US120534902024

  Methods and Compositions for Treating CD33+ Cancers and Improving in Vivo Persistence of Chimeric Antigen Receptor T Cells

  ST. JUDE CHILDREN'S RESEARCH HOSPITAL, Inc.

  0 cites